Strides Pharma Science Limited — Efavirenz Exporter Profile
Indian Pharmaceutical Exporter · #8 for Efavirenz · $611.0K export value · DGFT Verified
Strides Pharma Science Limited is the #8 Indian exporter of Efavirenz with $611.0K in export value and 55 verified shipments. Strides Pharma Science Limited holds a 1.1% market share in Efavirenz exports across 25 countries. The company exports 42 pharmaceutical products worth $179.3M across 20 therapeutic categories.
Strides Pharma Science Limited — Efavirenz Export Profile: Buyers & Destinations
Where Does Strides Pharma Science Limited Export Efavirenz?
| Country | Value | Shipments | Share |
|---|---|---|---|
| COSTA RICA | $50.0K | 1 | 12.2% |
| MYANMAR | $46.1K | 8 | 11.3% |
| COTE D IVOIRE | $43.9K | 1 | 10.8% |
| GEORGIA | $43.9K | 3 | 10.8% |
| UNITED STATES | $36.0K | 2 | 8.8% |
| UGANDA | $29.3K | 2 | 7.2% |
| GHANA | $24.6K | 1 | 6.0% |
| GUINEA | $22.6K | 2 | 5.5% |
| TAJIKISTAN | $18.7K | 1 | 4.6% |
| IVORY COAST | $15.9K | 1 | 3.9% |
Strides Pharma Science Limited exports Efavirenz to 26 countries. The largest destination is COSTA RICA accounting for 12.2% of Strides Pharma Science Limited's Efavirenz shipments, followed by MYANMAR (11.3%) and COTE D IVOIRE (10.8%). These destinations reflect Strides Pharma Science Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Efavirenz from Strides Pharma Science Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CAJA COSTARRICENSE DE SEGURO SOCIAL | COSTA RICA | $50.0K | 1 |
| NOUVELLE PHARMACIE DE LA | COTE D IVOIRE | $43.9K | 1 |
| NATIONAL CENTER FOR DISEASE CONTROL | GEORGIA | $40.2K | 2 |
| UNOPS MYANMAR OC | MYANMAR | $38.9K | 2 |
| NATIONAL MEDICAL STORES | UGANDA | $29.3K | 2 |
| STRIDES PHARMA INC, | UNITED STATES | $26.3K | 1 |
| MINISTRY OF HEALTH, GHANA | GHANA | $24.6K | 1 |
| MINISTERE DE LA SANTE (PROGRAMME NA | GUINEA | $19.8K | 1 |
| UNDP TAJIKISTAN | TAJIKISTAN | $18.7K | 1 |
| NOUVELLE PHARMACIE LA SANTE PUBLIQUEBP V | IVORY COAST | $15.9K | 1 |
Strides Pharma Science Limited supplies Efavirenz to 36 buyers globally. The largest buyer is CAJA COSTARRICENSE DE SEGURO SOCIAL (COSTA RICA), followed by NOUVELLE PHARMACIE DE LA (COTE D IVOIRE) and NATIONAL CENTER FOR DISEASE CONTROL (GEORGIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Efavirenz Export Value and How Much Does Strides Pharma Science Limited Contribute?
India exported $26.7M worth of Efavirenz through 1,084 shipments from 101 suppliers to 121 countries, serving 361 buyers globally. Strides Pharma Science Limited contributes $611.0K to this total, accounting for 1.1% of India's Efavirenz exports. Strides Pharma Science Limited ships Efavirenz to 26 countries through 36 buyers.
What Is the Average Shipment Value for Strides Pharma Science Limited's Efavirenz Exports?
Strides Pharma Science Limited's average Efavirenz shipment value is $11.1K per consignment, based on 55 shipments totaling $611.0K. The largest destination is COSTA RICA (12.2% of Strides Pharma Science Limited's Efavirenz exports).
How Does Strides Pharma Science Limited Compare to Other Indian Efavirenz Exporters?
Strides Pharma Science Limited ranks #8 among 101 Indian Efavirenz exporters with a 1.1% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($8.3M), MACLEODS PHARMACEUTICALS LTD ($6.0M), CIPLA LIMITED ($3.0M). Strides Pharma Science Limited processed 55 shipments to 25 destination countries.
What Efavirenz Formulations Does Strides Pharma Science Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EFAVIRENZ,EMTRICITABINE AND TENOFOVIR DI | $50.0K | 1 |
| EFAVIRENZ TABLETS 200MG (4382 X 90S) | $43.9K | 1 |
| EFAVIRENZ TABLETS (200MG) (FC) (3294 X 9 | $29.0K | 1 |
| Efavirenz Tablets [600mg] [FC] 3,456.00X | $26.3K | 1 |
| Efavirenz tablets [200mg] [FC] -(2718.00x 90 s) | $24.6K | 1 |
| EFAVIRENZ TABLETS [200mg][FC] PO NO : PO | $20.1K | 1 |
| (P/N:PO2202241) EFAVIRENZ TABLETS [200MG | $20.1K | 1 |
| Efavirenz tablets -200mg-FC - PONO 22019 | $19.8K | 1 |
| Efavirenz tablets [200mg] [FC] 2,016.00 | $18.7K | 1 |
| EFAVIRENZ TABLETS (200MG) (FC) PO NO:PO12400547 | $16.3K | 1 |
Strides Pharma Science Limited exports 45 distinct Efavirenz formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EFAVIRENZ,EMTRICITABINE AND TENOFOVIR DI with 1 shipments worth $50.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Strides Pharma Science Limited Compare to Nearest Efavirenz Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MICRO LABS LIMITED | $1.5M | 55 | 15 | $26.6K |
| 7 | AUROBINDO PHARMA LTD | $708.9K | 25 | 8 | $28.4K |
| 8 | STRIDES PHARMA SCIENCE LIMITED ★ | $611.0K | 55 | 25 | $11.1K |
| 10 | AUROBINDO PHARMA LIMITED | $363.3K | 11 | 3 | $33.0K |
| 9 | DELTA BIOPHARMA PRIVATE LIMITED | $300.0K | 6 | 2 | $50.0K |
Strides Pharma Science Limited ranks #8 among 101 Indian Efavirenz exporters. Average shipment value of $11.1K compared to the market average of $264.0K. The closest competitors by value are MICRO LABS LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Efavirenz Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 244 | 22.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 196 | 18.1% |
| Bombay Air | 89 | 8.2% |
| DELHI AIR CARGO ACC (INDEL4) | 73 | 6.7% |
| DELHI AIR | 64 | 5.9% |
| NHAVA SHEVA SEA (INNSA1) | 57 | 5.3% |
| JNPT/ NHAVA SHEVA SEA | 43 | 4.0% |
| BANGALORE ACC (INBLR4) | 30 | 2.8% |
Geopolitical & Trade Policy Impact on Strides Pharma Science Limited's Efavirenz Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Strides Pharma Science Limited. The Israel-Iran conflict has led to increased tensions in the Red Sea, a critical shipping route. This situation has resulted in higher shipping costs and potential delays, impacting the timely delivery of pharmaceutical products to key markets.
Conversely, ongoing trade tensions between the U.S. and China have opened avenues for Indian pharmaceutical companies. The U.S. is increasingly looking towards India as a reliable supplier of generic drugs, providing companies like Strides with opportunities to expand their footprint in the American market.
In the European Union, the implementation of the Falsified Medicines Directive (FMD) has imposed stringent compliance requirements. Indian exporters must adapt to these regulations to maintain market access. However, the recent India–EU Free Trade Agreement, concluded in January 2026, aims to eliminate tariffs on pharmaceuticals, potentially enhancing the competitiveness of Indian exporters in the European market. (en.wikipedia.org)
Strides Pharma Science Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Strides Pharma Science Limited has demonstrated a commitment to quality, as evidenced by the U.S. FDA's classification of its Chestnut Ridge facility in New York as "Voluntary Action Indicated" following an inspection in December 2025. This classification indicates that while some observations were noted, they are not expected to lead to regulatory action, reflecting the facility's adherence to Good Manufacturing Practices. (economictimes.indiatimes.com)
Such regulatory approvals are crucial for sustaining and expanding market presence, particularly in stringent markets like the U.S. and the EU. Continuous investment in compliance and quality assurance will be essential for Strides to navigate the evolving regulatory landscape effectively.
About Strides Pharma Science Limited
Strides Pharma Science Limited exports 42 products worth $179.3M. Beyond Efavirenz, top products include Ibuprofen, Rosuvastatin, Gabapentin, Vancomycin, Prednisone. View the complete Strides Pharma Science Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Efavirenz — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Efavirenz shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Strides Pharma Science Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 55 individual customs records matching Strides Pharma Science Limited exporting Efavirenz, covering 45 formulations to 26 countries via 36 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 121+ countries, 361+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Efavirenz Export Data from Strides Pharma Science Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Strides Pharma Science Limited's Efavirenz exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Strides Pharma Science Limited
Full Company Profile →
42 products · $179.3M total trade · 20 categories
Efavirenz Stats
Company Overview
Top Products by Strides Pharma Science Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Strides Pharma Science Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Efavirenz. For current shipment-level data, contact TransData Nexus.